Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
First, the control intervention, which bridges the comparison between acarbose and DPP-4is, should be the same and referring to the specific regimens and their doses
When examining a composite cardio outcomes endpoint (death from CV disease, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for unstable angina), the ELIXA trial suggested that GLP-1s did not increase cardiovascular event risk (hazard ratio of 1.02)
(Thousand Oaks, CA) 25
Pers and Lotte Bjerre Knudsen)
US$ 26.36
US$ 23.07
US$ 20.57
US$ 26.20
US$ 29.95
US$ 25.32
US$ 21.05
US$ 26.88
US$ 27.23
